Sagittarius Life Science Corp

Research Sagittarius Life Science Corp (3205.TWO) on Bullrun: market cap TWD 3.16B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker3205.TWO
ExchangeTWO
CountryTaiwan
SectorHealthcare
IndustryBiotechnology
CurrencyTWD
Market capTWD 3.16B
Financial periodQ2 2026
RevenueTWD 188.12M
Net income-TWD 1.65M
Free cash flow-TWD 172.40M
Gross margin4.8%

Valuation Snapshot

latest market cap is TWD 3.16B.

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	TWD 3.16B	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 TWD.

About Sagittarius Life Science Corp

Sagittarius Life Science Corp engages in the research, development, and sale of Chinese and western medicines, and health food products in Taiwan and Asia. It also offers organic food, daily necessities, and pet food; and engages in the research and development of biotechnology, as well as meat products. Sagittarius Life Science Corp was founded in 1998 and is based in Taipei, Taiwan.

Related stock research

Taiwan stocks Taiwan Healthcare stocks A-Z stock index

Other Healthcare stocks

Synbio Tech Inc. (1295.TWO) Sinphar Pharmaceutical Co.,Ltd. (1734.TW) Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) SYN-TECH Chem. & Pharm. Co., Ltd. (1777.TWO) Level Biotechnology Inc. (3118.TWO) GenMont Biotech Incorporation (3164.TW) Medigen Biotechnology Corp. (3176.TWO) NeoCore Technology Co., Ltd. (4131.TWO) Abnova (Taiwan) Corporation (4133.TW) Adimmune Corporation (4142.TW) TaiMed Biologics Inc. (4147.TWO) TaiGen Biopharmaceuticals Holdings Limited (4157.TWO)

Frequently asked questions

What is Sagittarius Life Science Corp's market cap?

Sagittarius Life Science Corp's market capitalization is TWD 3.16B.